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REDUCING BOVINE LEUKOSIS IN DAIRY CATTLE 
J. E. Shirley, J. F. Smith, G. L. Stokka,
R. K. Scoby, and T. Van Anne
Summary
Bovine leukosis virus (BLV) is a cancerous
condition of tissues in which lymph nodes and
lymphocytes are affected.  Infected cattle may
be identified by testing blood sera for BLV
antibodies using the agar gel immunodiffusion
(AGID) test that requires 2 days for processing.
Most dairy farms have infected animals, but the
condition is not considered important because
less than 1% of infected cattle show clinical
signs.  However, many of these cows are culled
because of poor milk production or reproduc-
tive performance.  Procedures for reducing
and(or) eliminating the disease are outlined.
Results obtained at the Kansas State University
Dairy Teaching and Research Center demon-
strate that feeding only colostrum and whole
milk from BLV-negative cows to newborn and
young calves is an effective method of reducing
the incidence of BLV in future generations.
(Key Words: Bovine Leukosis Virus, BLV-
Free Colostrum.)
Introduction
Most foreign markets demand bovine
leukemia (leukosis)-free heifers, semen, and
embryos.  Economically, this is a reason for
concern, because most dairies in the U.S. have
at least some cows that are infected.  Isolation
of the positive-testing cattle along with imple-
mentation of new management techniques,
which reduce accidental blood exposure from
seropositive to seronegative cattle, will reduce
the prevalence.
General Description
Bovine leukosis, bovine leukemia, lym-
phosarcoma, and malignant lymphoma are
names given to a retrovirus disease in cattle
caused by the bovine leukosis virus (BLV).  All
of these terms refer to a cancerous condition of
tissues in which lymph nodes and white blood
cells (lymphocytes) are affected.  Because
lymph nodes to which white blood cells
constantly circulate are located throughout the
body, the disease may localize in many areas.
True leukemias, where the entire body is af-
fected, are rare.  Most often, the condition
develops in other organs, if not a lymph node,
and is not expressed until the animal is an
adult.  Cattle with the adult or enzootic form of
bovine leukemia are usually 4 yr of age or
older, but it can occur as early as 2 yr of age.
Many of these cows are culled because of poor
milk production (over a period of a few days)
and, in some instances, may show poor appe-
tites followed by weight loss.  Poor appetite
may be due to throat tumors that lessen the
ability to swallow.  Because the signs of the
disease vary, many of the cows infected may be
identified as having another problem such as
hardware disease, abomasal problems, and
spinal cord injuries, especially affecting the
rear legs.  Abortions and infertility also may
occur if the uterus or other reproductive organs
are involved.  An exploratory rectal palpation
is the best diagnostic tool to locate internal
tumors, if peripheral lymph node enlargement
or exophthalmos are not observed.  Bovine
leukosis virus-infected cattle often are identi-
fied by testing sera for BLV antibodies using
the agar gel immunodiffusion (AGID) test that
requires 2 days to process.  Most dairy cows
are infected with the virus, but it often remains
in a dormant state until the animal is stressed,
such as during extremely hot or cold weather,
parturition, or illness.  BLV-infected cattle
show clinical signs less than 1% of the time,
but the number of cows being condemned at
the slaughter plants is increasing, suggesting
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that the number of cows infected is increasing
nationally.
Cattle become infected most often after
contact with blood from an infected animal.
Only .0005 milliliters of blood is needed for the
virus to infect a lymphocyte of a healthy ani-
mal.  Procedures such as injecting, castrating,
dehorning, and rectal palpation can spread the
virus, as well as blood sucking insects such as
horse flies.  Balling guns or any instrument that
comes in contact with cattle should be sanitized
properly after each use.  Natural service with a
bull also may contribute, because some blood
may be transferred during copulation, so artifi-
cial insemination is preferred.  Calves born to
infected dams contract the disease at birth
about 5% of the time.  Also, any calf fed BLV-
positive milk is at a greater risk of contracting
the disease.  Virus to antibody ratios can be
used to determine if a BLV-positive cow will
transfer the virus to her calf.  Cows exhibiting
high virus coupled with low antibody titer tend
to transfer the disease to their offspring,
whereas cows exhibiting low virus with a high
antibody titer tend to transfer immunity to their
offspring.
Breeders of registered cattle suffer the
biggest economic loss if animals are found
positive.  Many countries and U.S. companies
will not accept animals or animal products
infected with the virus.  Heifers or semen may
be rejected, causing a large monetary loss to the
heifer breeder or bull stud owner.  Some coun-
tries also require dams producing embryos to
be seronegative.  The economic impact to com-
mercial dairy producers includes reduced
performance, treatment and diagnosis costs, on-
farm death losses, condemned carcasses, and
cost of replacements.
To date, little evidence exists that the
disease is transmissible to humans.  Pasteur-
ization destroys the virus easily, and at room
temperature, outside of living cells, the virus
can live for only a few hours. Families that
consumed raw milk containing the virus were
studied and found to be free of BLV infection.
Veterinarians and others who work closely
with BLV-positive blood daily have not been
infected.
Prevalence in U.S. Dairy Cattle
The National Animal Disease Center re-
ported that the number of cows condemned at
slaughter because of lymph node tumors (lym-
phosarcomas) tripled between 1975 and 1990
and is nine times that found in Denmark during
the 1950’s before leukosis control and eradica-
tion programs began.  In 1992, only about 2%
of the cows infected with BLV got lymph node
tumors.  The total number of animals infected
with the virus has not been determined, but
during the 1970s, about 20% of cows were
estimated to be infected.  In 1984, some states
reported the prevalence of BLV-infected dairy
cattle: Wisconsin (22.2%), Florida (47.7%),
and Michigan (30%).  Beef cows had lower
rates ranging from .12 to 6.7%.
The increasing number of condemned
carcasses suggests that current management of
dairy cows is not preventing further BLV
infections.  Even though BLV is not easily
spread from animal to animal, licking of blood
and body secretions can contribute to its trans-
mission.  The higher the number of calves
housed together, the greater the risk.  Housing
heifers in larger groups and calf management
practices like gouge dehorning, eartagging, and
branding can contaminate feed areas and other
facilities with blood.  Multiple use of the same
needle during routine vaccinations, use of
unsterilized needles, and not changing gloves
during insemination or pregnancy testing also
can increase the number of BLV-positive
animals.
Elimination Program
Establishing new management and veteri-
nary practices is key to controlling the disease,
because no vaccine is available.
Blood testing is the first step, so BLV-
positive animals can be identified and grouped
separately.  Serological test results from ani-
mals younger than 6 mo of age may show false-
positive results because of colostral antibodies
that are still present.  Pregnant animals should
be serotested at least 6 wk before parturition to
prevent false-positive results from
immunoglobulins being shifted to colostrum.
The separation of infected animals alone will
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reduce incidence drastically when older BLV-
positive cows are replaced by BLV-negative
testing heifers.
Recommendations to reduce transmission
of BLV follow:
✓ Only single-use disposable needles and
palpation sleeves should be used and then
discarded.
✓ A complete cleaning should be performed
of all surgical instruments (those that come
into contact with blood), such as for
dehorning, castration, extra teat removal,
tagging, and tattooing.  These instruments
also should be disinfected between uses.
✓ Biting insect numbers also need to be re-
duced.
✓ All cattle entering the herd should be tested
for BLV and isolated for 30 to 60 days.
These cattle should then be tested again at
the end of the isolation period before enter-
ing the herd.
✓ Annual testing should be implemented for
all animals.  A 3- to 4-mo testing interval is
preferred but may be impractical. 
✓ Artificial insemination should be used for
all breedings.
✓ Neither colostrum nor milk should be used
from BLV-positive cows.  Milk replacer or
pasteurized milk should be fed to calves
when BLV-free milk is not available.
✓ Intravenous tubes or needles, like those
used to treat milk fever, should be stored in
a disinfectant solution, such as Nolvasan,
which is a good cold sterilizer.
✓ Calf delivery equipment also should be
cold sterilized between uses.
✓ Do not use BLV-positive cows as recipi-
ents for embryo transfer.  If a highly valu-
able donor is tested positive, implant
embryos in BLV-negative testing cows and
test the offspring of the donor to be sure
they are BLV-free.
✓ Use smaller pen sizes for calves.
✓ Remove extra teats, insert eartags, and de-
horn while calves are housed individually.
✓ Bloodless dehorning methods such as elec-
tric, hot iron, or caustic paste are recom-
mended.
✓ Regularly clean feed and water containers
to reduce blood contamination. 
✓ Perform all veterinary procedures on BLV-
positive cows last.
✓ Milk all BLV-positive cows last.
Complete eradication programs should be
implemented by dairies that sell heifers, em-
bryos, or semen so they can gain a BLV-free
status.  Some states have certification programs
to identify BLV-free dairy herds.  All states
have some requirements in common such as:
identification of sick animals by regular blood
testing, establishing practices and procedures to
prevent the spread of any blood or other fluids
from BLV-positive to BLV-negative animals,
and isolating infected from noninfected ani-
mals.  Culling rates also may increase to rid the
herd more quickly of positive cows and to
reduce exposure of healthy animals.
Procedures
Limited published data exist on the inci-
dence of BLV in U.S. dairy herds and even less
on the incidence in Kansas herds.  Further,
information relative to the success or failure of
recommended elimination procedures is lack-
ing.  A BLV testing and elimination program
was initiated in the Kansas State University
dairy herd in 1994 to provide data on the inci-
dence of BLV and the effectiveness of using
only colostrum and whole milk from cows
exhibiting a negative BLV titer to feed heifer
calves from birth to weaning.
All lactating cows and cows and heifers due
to calve within 30 days were tested during May
and June of 1994.  The remaining cows and
heifers were tested routinely when they were
moved to the maternity area approximately 21
days before projected calving date.  Colostrum
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and whole milk from cows testing negative
were used to feed heifer calves, whereas colos-
trum and whole milk from positive-testing
cows were fed to bull calves because they
would leave the herd at an early age.  Proce-
dures to eliminate transfer of the virus by
needle, artificial insemination, pregnancy
checking, blood sampling, and other mechani-
cal means were instituted in the mid 1980s.
Transfer by insect vectors and animal contact
remains a possibility.  
Results and Discussion
Approximately 55% of the 180 cows tested
for BLV in 1994 showed a positive titer.  One
hundred and eleven (111) cows and heifers
were tested for the first time in 1995, and
33.3% tested positive.  Eighty-eight heifer
calves have been tested for the first time in
1996 (January to August 15), and only 21.5%
tested positive.  Sixty-five of the heifers tested
in 1996 received colostrum and whole milk
from cows with a BLV-negative titer and only
12.3% tested positive.  The decline in the
percentage of positive-titer cows tested for the
first time in 1995 is attributed to the fact that
most of these were first calf heifers, whereas
the 1994 group contained primarily cows in
their second or greater lactation.  The rationale
was that heifers tested prior to 24 mo of age
may be infected but do not show a positive
titer.  To test this supposition, 70 cows that
were  negative when first tested were retested
prior to their next parturition (Table 2), and
17.1% showed a positive titer.  These data
strongly support the recommendation that all
BLV-negative cows should be retested annually
to ensure a clean colostrum and milk supply for
the next generation.  Other studies have sug-
gested that cows tested within 6 wk of parturi-
tion may show a false positive test.  Our data
do not support this suggestion.  Thirty-five
cows showing a positive titer on the first test
were retested, with 33 testing positive and 2
testing negative.  The two cows testing negative
were confirmed positive with a third test.
The theory has been advanced that calves
born to dams testing positive tend to be less
susceptible to BLV than cows born to dams
showing a negative titer.  Results in Table 3 do
not support this theory, because 19.4% of
calves from positive dams tested positive by 24
mo of age, whereas only 3.8% of the calves
from negative dams showed a positive titer.
Some reports suggest that 5 to 10% of calves
from cows showing a positive titer may acquire
the virus by blood transfer during the birthing
process.  This could account for the increased
number of positive titers in calves from positive
dams in this study, because all calves reported
in Table 3 received colostrum and whole milk
from negative cows.  However, definitive
conclusions on this point should not be made
from such a small sample population.
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Table 1. Incidence of Bovine Leukosis Virus in the KSU Dairy Herd1
Year
No. tested
1st time No. (+) % (+) No. (-) % (-)
1994 190 104 54.7 86 45.3
1995 111 37 33.3 74 66.7
1996 (Jan - Aug) 88 19 21.5 69 78.5
Program heifers2 65 8 12.3 57 87.7
All mature cows were tested in 1994, regardless of stage of lactation.  Bred heifers tested 211
days prior to projected calving date.  Figures for 1995 and 1996 include only bred heifers tested
for the first time 21 days prior to projected calving date.
Heifers that received colostrum and whole milk from (-) cows.2
Table 2. Value of Retesting Cows Showing Positive and Negative Titers for Bovine
Leukosis Virus1
No. Tested No. (+) % (+) No. (-) % (-)
(+) 1st test 35 33 94.3 2 5.7
(-) 1st test 70 12 17.1 58 82.9
Table 3. Incidence of Bovine Leukosis Virus in Heifers Born to (+) and (-) Dams
No. (+) % (+) (-) % (-)
Dam
(+) 31 6 19.4 25 80.6
(-) 26 1 3.8 25 96.2
No previous test 8 1 12.5 7 87.5
